Jong-Mu Sun

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article and Find Full Text PDF

October 2020

Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.

J Immunother Cancer 2020 10;8(2)

Samsung Genome Institute, Samsung Medical Center, Seoul, Korea

View Article and Find Full Text PDF

October 2020

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon Mutations: Are They Different from Those with Common Mutations?

Authors:

Hyun Ae Jung Sehhoon Park Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Myung-Ju Ahn Keunchil Park

Biology (Basel) 2020 Oct 7;9(10). Epub 2020 Oct 7.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

View Article and Find Full Text PDF

October 2020

Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.

Br J Cancer 2020 Dec 23;123(12):1720-1729. Epub 2020 Sep 23.

Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

December 2020

Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation.

Authors:

Jiyun Lee Joon Young Choi Sung Won Lim Myung-Ju Ahn Keunchil Park Jae Il Zo Young Mog Shim Dongryul Oh Jong-Mu Sun

Eur J Cardiothorac Surg 2020 Nov;58(5):1019-1026

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

November 2020

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?

Authors:

Jiyun Lee Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Keunchil Park Myung-Ju Ahn

J Thorac Dis 2020 Jul;12(7):3796-3803

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article and Find Full Text PDF

July 2020

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma.

Authors:

Jong-Mu Sun

Korean J Thorac Cardiovasc Surg 2020 Aug;53(4):168-171

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

August 2020

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.

Authors:

Hyera Kim Minsuk Kwon Binnari Kim Hyun Ae Jung Jong-Mu Sun Se-Hoon Lee Keunchil Park Myung-Ju Ahn

BMC Cancer 2020 Aug 5;20(1):727. Epub 2020 Aug 5.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article and Find Full Text PDF

August 2020

Evaluating entrectinib as a treatment option for non-small cell lung cancer.

Authors:

Jiyun Lee Sehhoon Park Hyun Ae Jung Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Keunchil Park Myung-Ju Ahn

Expert Opin Pharmacother 2020 Nov 31;21(16):1935-1942. Epub 2020 Jul 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Korea.

View Article and Find Full Text PDF

November 2020

Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors.

Authors:

Seokuee Kim Sujong Kim Young Suk Park Joon Oh Park Ho Yeong Lim Jin Seok Ahn Jeeyun Lee Jong Mu Sun Won Ki Kang RaeO Han Jungryul Kim Myung-Ju Ahn

Expert Opin Investig Drugs 2020 Sep 29;29(9):1059-1067. Epub 2020 Aug 29.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.

View Article and Find Full Text PDF

September 2020

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery.

Authors:

Sumin Shin Hong Kwan Kim Jong Ho Cho Yong Soo Choi Kwhanmien Kim Jhingook Kim Jae Ill Zo Jong-Mu Sun Myung-Ju Ahn Keunchil Park Hongryull Pyo Yong Chan Ahn Young Mog Shim

J Thorac Dis 2020 May;12(5):2602-2613

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

May 2020

EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.

Authors:

Sehhoon Park Bo Mi Ku Hyun Ae Jung Jong-Mu Sun Jin Seok Ahn Se-Hoon Lee Keunchil Park Myung-Ju Ahn

Cancer Res Treat 2020 Oct 22;52(4):1288-1290. Epub 2020 Jun 22.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

October 2020

Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.

Authors:

Sehhoon Park Joonho Shim Peter G S Mortimer Simon A Smith Robert E Godin Simon J Hollingsworth Hee-Jung Kim Hyun Ae Jung Jong-Mu Sun Woong-Yang Park Jin Seok Ahn Myung-Ju Ahn Se-Hoon Lee Keunchil Park

Cancer 2020 Sep 25;126(17):4002-4012. Epub 2020 Jun 25.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article and Find Full Text PDF

September 2020

Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).

Authors:

Hyun Ae Jung Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Myung-Ju Ahn Keunchil Park

Lung Cancer 2020 08 31;146:112-119. Epub 2020 May 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address:

View Article and Find Full Text PDF

August 2020

MDSC subtypes and CD39 expression on CD8 T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.

Authors:

Jiae Koh Youjin Kim Kyoung Young Lee Joon Young Hur Mi Soon Kim Boram Kim Hee Jin Cho Yeong Chan Lee Yeon Hee Bae Bo Mi Ku Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Keunchil Park Myung-Ju Ahn

Eur J Immunol 2020 11 9;50(11):1810-1819. Epub 2020 Jul 9.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.

View Article and Find Full Text PDF

November 2020

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer.

Authors:

Hyun Ae Jung Jae Myoung Noh Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Myung-Ju Ahn Hongryull Pyo Yong Chan Ahn Keunchil Park

Lung Cancer 2020 08 31;146:23-29. Epub 2020 May 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article and Find Full Text PDF

August 2020

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.

Nat Commun 2020 05 8;11(1):2285. Epub 2020 May 8.

Samsung Genome Institute, Samsung Medical Center, Seoul, 06351, Korea.

View Article and Find Full Text PDF

May 2020

Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma.

Authors:

Jiyun Lee Yoon La Choi Hyun Ae Jung Se-Hoon Lee Jin Seok Ahn Myung-Ju Ahn Keunchil Park Jong-Mu Sun

Eur J Cancer 2020 06 1;132:150-158. Epub 2020 May 1.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article and Find Full Text PDF

June 2020

Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With Exon 14 Skipping.

Authors:

Joon Young Hur Bo Mi Ku Joon Ho Shim Hyun Ae Jung Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Keunchil Park Myung-Ju Ahn

In Vivo 2020 May-Jun;34(3):1399-1406

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

View Article and Find Full Text PDF

February 2021

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Authors:

Han Gyul Yoon Dongryul Oh Yong Chan Ahn Jae Myoung Noh Hongryull Pyo Won Kyung Cho Yun Mi Song Minsu Park Na Young Hwang Jong-Mu Sun Hong Kwan Kim Jae Ill Zo Young Mog Shim

Cancers (Basel) 2020 Apr 10;12(4). Epub 2020 Apr 10.

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

View Article and Find Full Text PDF

April 2020

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer.

Authors:

Sung Hee Lim Jong-Mu Sun Joohyun Hong Dongryul Oh Yong Chan Ahn Man Ki Chung Han-Sin Jeong Young-Ik Son Myung-Ju Ahn Chung-Hwan Baek Keunchil Park

Korean J Intern Med 2020 Apr 3. Epub 2020 Apr 3.

Division of Hematology-Oncology, Department of Medicine, , Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

April 2020

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors.

Authors:

Dong Young Jeong Kyung Soo Lee Joon Young Choi Myung Jin Chung Yang Won Min Hong Kwan Kim Jae Ill Zo Young Mog Shim Jong-Mu Sun

Sci Rep 2020 03 19;10(1):5077. Epub 2020 Mar 19.

Division of Hemato-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (SKKU-SOM), Seoul, South Korea.

View Article and Find Full Text PDF

March 2020

Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.

Authors:

Jiyun Lee Hong Sook Kim Boram Lee Hee Kyung Kim Jong-Mu Sun Jin Seok Ahn Myung-Ju Ahn Keunchil Park Se-Hoon Lee

Cancer 2020 06 10;126(11):2704-2712. Epub 2020 Mar 10.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

June 2020

Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.

Authors:

Jiyun Lee Bo Mi Ku Joon Ho Shim Yoon La Choi Jong-Mu Sun Se-Hoon Lee Jin Seok Ahn Keunchil Park Myung-Ju Ahn

Jpn J Clin Oncol 2020 May;50(5):594-601

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

May 2020

Publications by authors named "Jong-Mu Sun"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: